EP4217001A4 - Composition and method for prevention and treatment of cutaneous radiation injury - Google Patents

Composition and method for prevention and treatment of cutaneous radiation injury Download PDF

Info

Publication number
EP4217001A4
EP4217001A4 EP21873367.3A EP21873367A EP4217001A4 EP 4217001 A4 EP4217001 A4 EP 4217001A4 EP 21873367 A EP21873367 A EP 21873367A EP 4217001 A4 EP4217001 A4 EP 4217001A4
Authority
EP
European Patent Office
Prior art keywords
prevention
treatment
composition
radiation injury
cutaneous radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21873367.3A
Other languages
German (de)
French (fr)
Other versions
EP4217001A1 (en
Inventor
Reginald L. HARDY
Mitchell Brigell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rythera Therapeutics Inc
Original Assignee
Rythera Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rythera Therapeutics Inc filed Critical Rythera Therapeutics Inc
Publication of EP4217001A1 publication Critical patent/EP4217001A1/en
Publication of EP4217001A4 publication Critical patent/EP4217001A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21873367.3A 2020-09-22 2021-09-22 Composition and method for prevention and treatment of cutaneous radiation injury Pending EP4217001A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063081547P 2020-09-22 2020-09-22
US202063081718P 2020-09-22 2020-09-22
PCT/US2021/051583 WO2022066791A1 (en) 2020-09-22 2021-09-22 Composition and method for prevention and treatment of cutaneous radiation injury

Publications (2)

Publication Number Publication Date
EP4217001A1 EP4217001A1 (en) 2023-08-02
EP4217001A4 true EP4217001A4 (en) 2024-04-24

Family

ID=80857195

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21873367.3A Pending EP4217001A4 (en) 2020-09-22 2021-09-22 Composition and method for prevention and treatment of cutaneous radiation injury

Country Status (7)

Country Link
EP (1) EP4217001A4 (en)
JP (1) JP2023544448A (en)
AU (1) AU2021349237A1 (en)
CA (1) CA3193398A1 (en)
IL (1) IL301530A (en)
MX (1) MX2023003357A (en)
WO (1) WO2022066791A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024064898A2 (en) * 2022-09-22 2024-03-28 Rythera Therapeutics Inc. Composition and method for prevention and treatment of cutaneous radiation injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621038A1 (en) * 1996-05-24 1997-11-27 Boehringer Ingelheim Kg Aminoguanidines, processes for their preparation and medicaments containing these compounds
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
CN101605763B (en) * 2006-12-21 2016-03-09 彼得·麦卡勒姆癌症研究所 Radioprotector compounds and methods involving
WO2009051628A2 (en) * 2007-09-06 2009-04-23 Arezou Petrie Transdermal treatment device and method
US9616006B2 (en) * 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
US20150353912A1 (en) * 2012-05-31 2015-12-10 Children's Hospital Medical Center Methods for treating and preventing radiation injury using activated protein c polypeptides
WO2016142341A1 (en) * 2015-03-06 2016-09-15 Repoceuticals Aps Melatonin for preventing and treating radiation vaginitis and proctitis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Doxepin rinse for oral mucositis", DENTAL ABSTRACTS, MOSBY, ST. LOUIS, MO, US, vol. 54, no. 1, 1 January 2009 (2009-01-01), pages 54 - 55, XP025891715, ISSN: 0011-8486, [retrieved on 20090127], DOI: 10.1016/J.DENABS.2008.08.049 *
BERGER BERNHARD ET AL: "Severe skin reaction secondary to concomitant radiotherapy plus cetuximab", RADIATION ONCOLOGY, BIOMED CENTRAL LTD, LO, vol. 3, no. 1, 28 January 2008 (2008-01-28), pages 5, XP021039595, ISSN: 1748-717X *
KAWASHITA YUMIKO ET AL: "Oral management strategies for radiotherapy of head and neck cancer", JAPANESE DENTAL SCIENCE REVIEW, ELSEVIER, AMSTERDAM, NL, vol. 56, no. 1, 20 February 2020 (2020-02-20), pages 62 - 67, XP086387121, ISSN: 1882-7616, [retrieved on 20200220], DOI: 10.1016/J.JDSR.2020.02.001 *
LALEH SHARIATI ET AL: "Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENTIFIC PUBL, GB, vol. 86, no. 9, 25 February 2020 (2020-02-25), pages 1875 - 1881, XP071603255, ISSN: 0306-5251, DOI: 10.1111/BCP.14238 *
LEE JEFFREY K ET AL: "ASGE guideline on the role of endoscopy for bleeding from chronic radiation proctopathy", GASTROINTESTINAL ENDOSCOPY, ELSEVIER, NL, vol. 90, no. 2, 22 June 2019 (2019-06-22), pages 171, XP085743421, ISSN: 0016-5107, [retrieved on 20190622], DOI: 10.1016/J.GIE.2019.04.234 *
See also references of WO2022066791A1 *

Also Published As

Publication number Publication date
WO2022066791A1 (en) 2022-03-31
IL301530A (en) 2023-05-01
EP4217001A1 (en) 2023-08-02
JP2023544448A (en) 2023-10-23
AU2021349237A1 (en) 2023-06-08
CA3193398A1 (en) 2022-03-31
MX2023003357A (en) 2023-06-30

Similar Documents

Publication Publication Date Title
EP4119156A4 (en) Medicament for treatment and/or prevention of cancer
EP4217001A4 (en) Composition and method for prevention and treatment of cutaneous radiation injury
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4091621A4 (en) Method for treatment of nerve injury and related disease
EP4110369A4 (en) Methods of treatment and related compositions
EP3750529A4 (en) Composition for prevention and treatment of spinal cord injury
EP4119159A4 (en) Medicament for treatment and/or prevention of cancer
EP4119160A4 (en) Medicament for treatment and/or prevention of cancer
EP4119157A4 (en) Medicament for treatment and/or prevention of cancer
EP4119158A4 (en) Medicament for treatment and/or prevention of cancer
EP4114864A4 (en) Compositions and methods for treatment of cancer
EP4136072A4 (en) Compositions and methods for treating pain and/or inflammation
EP4099997A4 (en) Methods and compositions for treatment of diseases
EP3982999A4 (en) Composition for and method of treating hepatic tissue injury
EP3917619A4 (en) Structurally modified opioids for prevention and treatment of diseases and conditions
EP4135743A4 (en) Prevention and treatment of organ injuries
AU2022901758A0 (en) Method and apparatus for the treatment of human conditions
EP4125920A4 (en) Methods and compositions for treatment of covid-19
AU2021902069A0 (en) Methods of treatment and inhibition
AU2021902598A0 (en) Method of treating and/or preventing cancer
GB202107966D0 (en) Composition and method of treatment
EP4110923A4 (en) Methods and compositions for treatment of apc-deficient cancer
EP4093484A4 (en) Methods and materials for treating nerve injury and/or promoting wound healing
EP4168408A4 (en) Compounds for and methods of treating diseases
AU2020903058A0 (en) Compounds for and Methods of Treating Diseases

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230420

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0041000000

Ipc: A61K0031135000

A4 Supplementary search report drawn up and despatched

Effective date: 20240326

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20240320BHEP

Ipc: A61K 9/02 20060101ALI20240320BHEP

Ipc: A61K 9/00 20060101ALI20240320BHEP

Ipc: A61P 43/00 20060101ALI20240320BHEP

Ipc: A61P 17/02 20060101ALI20240320BHEP

Ipc: A61K 41/00 20200101ALI20240320BHEP

Ipc: A61K 31/135 20060101AFI20240320BHEP